Frequency of Hyponatraemia in Patients Admitted With Community Acquired Pneumonia in Medical Unit of Teaching Hospital

Authors

  • Salman Khan
  • Abdur Rehman
  • Muhammad Zubair
  • Moeen ul Haq
  • Nisar Khan

DOI:

https://doi.org/10.1996/pjcm.v28i3.807

Keywords:

Community-acquired Pneumonia, Hyponatraemia, SIAD

Abstract

Background: Hyponatraemia is frequently found in community-acquired pneumonia (CAP) and contributes to a higher rate of morbidity and mortality. There is a paucity of data on the mechanism and treatment of hyponatremia in CAP Objectives: the aim of the present study was to determine the frequency of hyponatremia in patients admitted with community-acquired pneumonia in tertiary care hospital. Methodology: This prospective observational study was carried out on 1246 CAP patients admitted to the Medical Unit of DHQ hospital, Dera Ismail Khan from July 2020 to January 2022. Patients who experienced the onset of pneumonia and hyponatremia (with sodium levels ≤ 130 mmol/L) within the initial 48 hours of admission were incorporated into the study. In a total of eligible patient’s admissions for community-acquired pneumonia (CAP), the prevalence and corresponding mortality rates for each subtype of hyponatremia were investigated. A subgroup of patients diagnosed with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIAD) was actively observed over time to record and study the natural progression of SIAD in the context of community-acquired pneumonia (CAP). Results: The prevalence of hyponatremia (≤130 mmol/l) in CAP patients was 9.5% (n=118). Among 118 hyponatraemia patients, the incidence of euvolaemic hyponatremia, hypovolemic hyponatremia (HEN) and hypotonic hyponatremia (HON) was 50.8% (n=60), 8.5% (n=10) and 40.7% (n=48) respectively. Out of 60 euvolaemic hyponatremia cases, the incidence of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIAD) and steroid deficiency was 47.5% (n=56) and 3.4% (n=4) respectively. Hypovolemic hyponatremia consistently stemmed from concurrent congestive cardiac failure. The mortality rate was elevated among individuals in the HEN group compared to those in the HON, SIAD, or normonatraemic groups. The plasma sodium concentration returned to normal levels in 7 out of 10 patients (70%) by day 7. Among the three patients who continued to experience hyponatremia, underlying bronchiectasis was identified as the cause. Conclusion: In cases of community-acquired pneumonia (CAP), hyponatremia is typically attributed to either the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIAD) or hypovolemia. However, it's important to note that while Hypovolemic Euvolemic Hyponatremia (HEN) is less frequently encountered, it carries a more adverse prognosis. Keywords: Community-acquired pneumonia; Hyponatraemia; SIAD

Author Biographies

Salman Khan

Department of Medicine, DHQ Teaching Hospital, Gomal Medical College, Dera Ismail Khan – Pakistan

Abdur Rehman

Department of Medicine, DHQ Teaching Hospital, Gomal Medical College, Dera Ismail Khan – Pakistan

Muhammad Zubair

Department of Medicine, DHQ Teaching Hospital, Dera Ismail Khan - Pakistan

Moeen ul Haq

Department of Medicine, DHQ Teaching Hospital, Gomal Medical College, Dera Ismail Khan – Pakistan

Nisar Khan

Department of Medicine, MMM Teaching Hospital, Gomal Medical College, Dera Ismail Khan – Pakistan

References

Cuesta M, Slattery D, Goulden EL, Gupta S, Tatro E, Sherlock M, et al. Hyponatraemia in patients with communityâ€acquired pneumonia; prevalence and aetiology, and natural history of SIAD. Clin End. 2019;90(5):744-52.

Verbalis JG. Euvolemic hyponatremia secondary to the syndrome of inappropriate antidiuresis. Disorders of Fluid and Electrolyte Metabolism. Front Hormone Res. 2019;52:61-79. DOI: 10.1159/000493238.

Lu H, Vollenweider P, Kissling S, Marques-Vidal P. Prevalence and description of hyponatremia in a Swiss tertiary care hospital: an observational retrospective study. Front Med (Lausanne). 2020;7:512. DOI:10.3389/fmed.2020.00512.

Garrahy A, Thompson CJ. Hyponatremia and glucocorticoid deficiency. Front Horm Res. 2019;52:80-92. DOI:10.1159/000493239

Martin-Grace J, Dineen R, Sherlock M, Thompson CJ. Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges. Clin Chim Acta. 2020;505:78-91. DOI:10.1016/j.cca.2020.01.029.

Cuesta M, Garrahy A, Slattery D, Gupta S, Hannon AM, McGurren K, et al. Mortality rates are lower in SIAD, than in hypervolaemic or hypovolaemic hyponatraemia: results of a prospective observational study. Clin Endocrinol. 2017;87(4):400-6.

Cuesta M, Garrahy A, Slattery D, Gupta S, Hannon AM, Forde H, et al. The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: results of a large prospective singleâ€centre study. Clin Endocrinol. 2016;85(6):836-44.

Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, et al. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Euro J Endocrinol. 2015;173(5):633-42.

Ramanathan S, Kumar P, Mishra K, Dutta AK. Isotonic versus Hypotonic Parenteral Maintenance Fluids in Very Severe Pneumonia. Indian J Pediatr. 2016;83(1):27-32.

Verbalis JG, Greenberg A, Burst V, Haymann JP, Johannsson G, Peri A, et al. Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion. Am J Med. 2016;129(5):537-e9.

Knechtle B, Chlíbkova D, Papadopoulou S, Mantzorou M, Rosemann T, Nikolaidis PT. Exercise-associated hyponatremia in endurance and ultra-endurance performance-aspects of sex, race location, ambient temperature, sports discipline, and length of performance: a narrative review. Medicina. 2019;55(9):537. DOI:10.3390/medicina55090537.

Sailer CO, Winzeler B, Nigro N, Suterâ€Widmer I, Arici B, Bally M, et al. Characteristics and outcomes of patients with profound hyponatraemia due to primary polydipsia. Clin Endocrinol. 2017;87(5):492-9. DOI:10.1111/cen.13384.

Girardeau Y, Jannot AS, Chatellier G, Saint-Jean O. Association between borderline dysnatremia and mortality insight into a new data mining approach. BMC Med Inform Decis Mak. 2017;17(1):152. DOI:10.1186/s12911-017-0549-7

Thorpe O, Cuesta M, Fitzgerald C, Feely O, Tormey WP, Sherlock M, et al. Active management of hyponatraemia and mortality in older hospitalised patients compared with younger patients: results of a prospective cohort study. Age and ageing. 2021;50(4):1144-50. DOI:10.1093/ageing/afaa248.

Kutz A, Ebrahimi F, Aghlmandi S, Wagner U, Bromley M, Illigens B, et al. Risk of adverse clinical outcomes in hyponatremic adult patients hospitalized for acute medical conditions: a population-based cohort study. J Clin Endocrinol Met. 2020;105(11):3428-36. DOI:10.1210/clinem/dgaa547.

Suárez V, Norello D, Sen E, Todorova P, Hackl MJ, Hüser C, et al. Impairment of neurocognitive functioning, motor performance, and mood stability in hospitalized patients with euvolemic moderate and profound hyponatremia. American J Med. 2020;133(8):986-93. DOI:10.1016/j.amjmed.2019.12.056.

Boyer S, Gayot C, Bimou C, Mergans T, Kajeu P, Castelli M, et al. Prevalence of mild hyponatremia and its association with falls in older adults admitted to an emergency geriatric medicine unit (the MUPA unit). BMC Geriatrics. 2019;19(1):1-6. DOI:10.1186/s12877-019-1282-0.

Garrahy A, Dineen R, Hannon AM, Cuesta M, Tormey W, Sherlock M, Thompson CJ. Continuous versus bolus infusion of hypertonic saline in the treatment of symptomatic hyponatremia caused by SIAD. J Clin Endocrinol Met. 2019;104(9):3595-602. DOI:10.1210/jc.2019-00044.

Baek SH, Jo YH, Ahn S, Medina-Liabres K, Oh YK, Lee JB, Kim S. Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial. JAMA Int Med. 2021;181(1):81-92. DOI:10.1001/jamainternmed.2020.5519.

Garrahy A, Galloway I, Hannon AM, Dineen R, O’Kelly P, Tormey WP, et al. Fluid restriction therapy for chronic SIAD; results of a prospective randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism. 2020;105(12):e4360-9. DOI: 10.1210/clinem/dgaa619.

Shoaf SE, Bricmont P, Dandurand A. Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults. Eur J Clin Pharmacol. 2017;73(11):1399-1408. DOI:10.1007/s00228-017-2302-7.

Berkman K, Haigh K, Li L, Lockett J, Dimeski G, Russell A, et al. Investigation and management of moderate to severe inpatient hyponatraemia in an Australian tertiary hospital. BMC Endo Dis. 2018;18(1):1-7. DOI:10.1186/s12902-018-0320-9.

McGreal K, Budhiraja P, Jain N, Yu AS. Current challenges in the evaluation and management of hyponatremia. Kid Dis. 2016;2(2):56-63.

Kumar A, Ghosh M, Jacob JJ. Prevalence of adrenal insufficiency among patients with euvolemic hyponatremia. Endocr Connect. 2021, 10:1623-31. DOI: 10.1530/EC-21-0500.

Mazhar F, Pozzi M, Gentili M, Scatigna M, Clementi E, Radice S, et al. Association of hyponatraemia and antidepressant drugs: a pharmacovigilance–pharmacodynamic assessment through an analysis of the US food and drug administration adverse event reporting system (FAERS) database. CNS Drugs. 2019;33:581-92.

Downloads

Published

2022-09-02

How to Cite

Salman Khan, Abdur Rehman, Muhammad Zubair, Moeen ul Haq, & Nisar Khan. (2022). Frequency of Hyponatraemia in Patients Admitted With Community Acquired Pneumonia in Medical Unit of Teaching Hospital. Pakistan Journal of Chest Medicine, 28(3), 297–301. https://doi.org/10.1996/pjcm.v28i3.807

Issue

Section

Original Article